Ivermectin has shot to fame over the last year - or infamy, depending on your perspective. Despite more than enough data showing demonstrable success in treating covid-19 as well as acting as a potent prophylactic, it’s hitting massive roadblocks to widescale adoption. But why has this humble, hardworking, long-used, generic drug become the driver of mass censorship, outright bullying and bureaucratic red tape?

This week our founder, Rob Verkerk PhD, interviewed Dr Tess Lawrie, one of the most learned international experts on Ivermectin, to get to the bottom of why this old drug has become more about politics than health.

What is Ivermectin and who is Dr Tess Lawrie?

But before you dive into the video, and just to clarify, ivermectin is a Nobel prize winning generic drug on the WHO's Essential Drugs list. It’s been in use for more than 40 years with an estimated 3.7 billion doses and is being considered for mass administration for malaria by the WHO.

Ivermectin is endorsed by Dr Pierre Kory of the Front-Line Covid-19 Critical Care Alliance (FLCCC), authors of now renowned MATH+ hospital treatment protocol for covid-19 and the I-MASK protocol for prevention and early outpatient treatment. Anecdotal evidence is mounting to suggest it’s useful for long-covid or long-hauler syndrome too. Ivermectin is usually used as an anti-parasitic (worms, river blindness), but is now recognised as a broad anti-viral and anti-bacterial, with potential as a chemotherapy adjuvant for cancer.

Dr Tess Lawrie MBBCh DFSRH PhD is the director of the Evidence-Based Medicine Consultancy Ltd, which is committed to improving the quality of healthcare through rigorous research. Her range of research expertise, based on research experience in both developing and developed countries, uniquely positions her to evaluate and design research for a variety of healthcare settings. Dr Lawrie is a frequent member of technical teams responsible for developing international guidelines. Her peer-reviewed publications have received in excess of 3000 citations and her ResearchGate score is among the top 5% of ResearchGate members.

Dr Lawrie decided to take a stand on ivermectin after seeing Dr Pierre Kory testify before the US Senate on the potential of ivermectin for prevention and treatment of covid-19. She looked into the data and decided to conduct a rapid systematic review and meta-analysis to assess the data for herself. She was struck by the seeming efficacy of the drug in reducing mortality and morbidity, and, as a doctor, considered it her duty to inform the UK health authorities about this potential breakthrough treatment.

To date, her efforts to reach the UK Govt have been met with stony silence. Instead, she's been censored, deplatformed, villified and pilloried. But Dr Lawrie has worked tirelessly to keep getting the message out on ivermectin through countless interviews, testifying in court and making presentations to governments and medical professional groups around the world.


>>> Follow Dr Lawie's work on ivermectin by subscribing to the BIRD (British Ivermectin Recommendation Development Group) website.

Watch the interview

Note: You will see an advertising banner beneath our videos that play off the Brighteon platform (when they are not maximised). This advertising helps support the Brighteon platform that doesn't charge subscribers for their content, is committed to free speech, yet is also respectful of copyright-related law. We'd like to clarify that no advertising revenue from Brighteon is received by the Alliance for Natural Health Intl.


>>> Visit ANH-Intl's vast curation of articles and media that has followed the pandemic over the last year

>>> Return to our homepage

>>> Please consider supporting our work with a donation or by joining as an ANH Pathfinder